Global Genetic Testing Market Forecast to 2023 - Segmented by Treatment Type, Diseases, and Technology - ResearchAndMarkets.com

DUBLIN--()--The "Global Genetic Testing Market - Segmented by Treatment Type, Diseases, Technology and Geography - Growth, Trends and Forecasts (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

As of 2017, the global genetic testing market was valued at USD 9,367 million and is expected to record a CAGR of around 10.4% during the forecast period (2017-2023).

In 2017, the North American genetic testing segment of the market studied accounted for the highest revenue and Asia-Pacific is expected to register the highest CAGR of 12.6% over the forecast period.

Growing Demand for Personalized Medicine: Personalized medicine, where tailored therapy is made available to patients with an understanding of the molecular basis of diseases, has become popular over the recent years. Genetic testing and genome sequencing are two of the most important tools that are used to understand the molecular basis of a disease. European countries are screened for several genetic diseases, as an early detection of these diseases can prevent the onset of symptoms, or minimize the severity of the disease. Genetic testing for cancer diagnosis can indicate the predisposition of the disease in the gene, before its actual manifestation. This type of diagnostic technique enables a person to take precautionary steps, and avoid possible risks in the future.

Market Dynamics

Drivers

  • Increasing Emphasis on Early Disease Detection and Prevention
  • Growing Demand for Personalized Medicine
  • Increasing Application of Genetic Testing in Oncology

Restraints

  • High Costs of Genetic Testing
  • Social and Ethical Implications of Genetic Testing

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • 23 And Me Inc.
  • Abbott Molecular Inc.
  • Ariosa Diagnostics Inc.
  • Biocartis Sa
  • Cepheid
  • Illumina Inc.
  • Luminex Corporation
  • Sequenom Inc.
  • Myriad Genetics
  • Transgenomic Inc.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/g6kxdc/global_genetic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics